BioSpace News Archive

Nexcella, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for BCMA CAR-T NXC-201 (formerly HBI0101).

MIRA Pharmaceuticals, Inc. today revealed groundbreaking insights into the cognitively enhancing effects of MIRA1a in normal mice during a presentation at the University of Louisville’s Christine Lee Brown Envirome Institute’s Grand Rounds.

Biocom California, the association representing the California life sciences industry, has announced that Andrés Bratt-Leal, PhD, Aspen Neuroscience co-founder and senior vice-president of research and development, is a recipient of the 2023 Life Science Catalyst Awards.

MIRA Pharmaceuticals, Inc. today announced it will host a shareholder update call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time.

Legacy Healthcare, a clinical-stage biopharmaceutical company developing transformative medicines for the treatment of autoimmune and inflammatory diseases, continues to be featured in news outlets highlighting the company’s lead drug candidate, Coacillium, for the treatment of moderate and severe alopecia areata in children and adolescents.

Samsung will feature the latest innovation in cutting-edge mobile computed tomography, including the state-of-the-art OmniTom Elite with Photon Counting Detector (PCD) technology.

Medigene AG announced an update and prioritization of its pipeline and resource allocation to support the execution of its long-term corporate strategy.

The Executive Management Board of Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, adjusted financial guidance for fiscal year 2023.

Medline announced that it has awarded grants to 10 non-profit organizations through its annual Community Impact Grant program.

Poolbeg Pharma announces that the Japanese Patent Office has notified the Company of its official decision to grant Poolbeg’s Immunomodulator II patent application.